drugset / Trial / NCT06122389
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was designed to compare the efficacy and safety of SHR2554 with Chidamide in patients with relapsed/refractory PTCL.
Timeline
- Start
- 2024-02-05
- Primary completion
- 2026-05
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR2554 | Small molecule | — | — |
| Subject | Tucidinostat | Small molecule | — | — |